Dynamic Contrast-Enhanced CT in Patients with Pancreatic Cancer
- PMID: 27608045
- PMCID: PMC5039568
- DOI: 10.3390/diagnostics6030034
Dynamic Contrast-Enhanced CT in Patients with Pancreatic Cancer
Abstract
The aim of this systematic review is to provide an overview of the use of Dynamic Contrast-enhanced Computed Tomography (DCE-CT) in patients with pancreatic cancer. This study was composed according to the PRISMA guidelines 2009. The literature search was conducted in PubMed, Cochrane Library, EMBASE, and Web of Science databases to identify all relevant publications. The QUADAS-2 tool was implemented to assess the risk of bias and applicability concerns of each included study. The initial literature search yielded 483 publications. Thirteen articles were included. Articles were categorized into three groups: nine articles concerning primary diagnosis or staging, one article about tumor response to treatment, and three articles regarding scan techniques. In exocrine pancreatic tumors, measurements of blood flow in eight studies and blood volume in seven studies were significantly lower in tumor tissue, compared with measurements in pancreatic tissue outside of tumor, or normal pancreatic tissue in control groups of healthy volunteers. The studies were heterogeneous in the number of patients enrolled and scan protocols. Perfusion parameters measured and analyzed by DCE-CT might be useful in the investigation of characteristic vascular patterns of exocrine pancreatic tumors. Further clinical studies are desired for investigating the potential of DCE-CT in pancreatic tumors.
Keywords: DCE-CT; diagnostics; pancreatic cancer; scan techniques; treatment response.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Assessing Tumor Response to Treatment in Patients with Lung Cancer Using Dynamic Contrast-Enhanced CT.Diagnostics (Basel). 2016 Jul 21;6(3):28. doi: 10.3390/diagnostics6030028. Diagnostics (Basel). 2016. PMID: 27455330 Free PMC article. Review.
-
Dynamic contrast-enhanced micro-computed tomography correlates with 3-dimensional fluorescence ultramicroscopy in antiangiogenic therapy of breast cancer xenografts.Invest Radiol. 2014 Jul;49(7):445-56. doi: 10.1097/RLI.0000000000000038. Invest Radiol. 2014. PMID: 24598441
-
Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer.Acta Oncol. 2013 Oct;52(7):1360-8. doi: 10.3109/0284186X.2013.813637. Epub 2013 Sep 5. Acta Oncol. 2013. PMID: 24003852
-
Development of a dynamic flow imaging phantom for dynamic contrast-enhanced CT.Med Phys. 2011 Aug;38(8):4866-80. doi: 10.1118/1.3615058. Med Phys. 2011. PMID: 21928658
-
Diagnostic accuracy of flat-panel computed tomography in assessing cerebral perfusion in comparison with perfusion computed tomography and perfusion magnetic resonance: a systematic review.Neuroradiology. 2019 Dec;61(12):1457-1468. doi: 10.1007/s00234-019-02285-y. Epub 2019 Sep 16. Neuroradiology. 2019. PMID: 31523757 Free PMC article.
Cited by
-
Combination of DCE-MRI and DWI in Predicting the Treatment Effect of Concurrent Chemoradiotherapy in Esophageal Carcinoma.Biomed Res Int. 2020 Jun 16;2020:2576563. doi: 10.1155/2020/2576563. eCollection 2020. Biomed Res Int. 2020. PMID: 32626736 Free PMC article.
-
Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRI.Clin Cancer Res. 2020 Sep 15;26(18):5007-5018. doi: 10.1158/1078-0432.CCR-18-1359. Epub 2020 Jul 1. Clin Cancer Res. 2020. PMID: 32611647 Free PMC article.
-
Multitasking dynamic contrast enhanced magnetic resonance imaging can accurately differentiate chronic pancreatitis from pancreatic ductal adenocarcinoma.Front Oncol. 2023 Jan 6;12:1007134. doi: 10.3389/fonc.2022.1007134. eCollection 2022. Front Oncol. 2023. PMID: 36686811 Free PMC article.
References
-
- American Cancer Society . Cancer Facts & Figures 2016. American Cancer Society; Atlanta, GA, USA: 2016.
-
- Ducreux M., Cuhna A.S., Caramella C., Hollebecque A., Burtin P., Goere D., Seufferlein T., Haustermans K., Van Laethem J.L., Conroy T., et al. Cancer of the pancreas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2015;26(Suppl. S5):v56–v68. doi: 10.1093/annonc/mdv295. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources